Pemazyre Prices, Coupons, Copay Cards & Patient Assistance
Pemazyre (pemigatinib) is a member of the multikinase inhibitors drug class and is commonly used for Cholangiocarcinoma, and Myeloid/Lymphoid Neoplasms.
The cost for Pemazyre 4.5 mg oral tablet is around $19,759 for a supply of 14 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Pemazyre is available as a brand name drug only, a generic version is not yet available. View generic Pemazyre availability for more details.
Pemazyre prices
Oral Tablet
4.5 mg
Pemazyre oral tablet
from $19,758.52
for 14 tablets
Quantity | Per unit | Price |
---|---|---|
14 | $1,411.32 | $19,758.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
9 mg
Pemazyre oral tablet
from $19,758.52
for 14 tablets
Quantity | Per unit | Price |
---|---|---|
14 | $1,411.32 | $19,758.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
13.5 mg
Pemazyre oral tablet
from $19,758.52
for 14 tablets
Quantity | Per unit | Price |
---|---|---|
14 | $1,411.32 | $19,758.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Pemazyre Coupons, Copay Cards and Rebates
Pemazyre offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Pemazyre IncyteCARES Savings Program
Eligible commercially insured patients may pay $0 per 30-day prescription; limit one 30-day supply per 30 days; program resets each calendar year.
- Applies to:
- Pemazyre
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-452-5234 or Visit website
Pemazyre IncyteCARES Temporary Access Program
Eligible commercially insured patient may receive a FREE 30-day supply if experiencing a delay in coverage.
- Applies to:
- Pemazyre
- Number of uses:
- Temporary Assistance
Form more information phone: 855-452-5234 or Visit website
Patient Assistance & Copay Programs for Pemazyre
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Pemazyre (pemigatinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: IncyteCARES for Pemazyre Patient Assistance Program
Eligibility requirements:- Must be uninsured or underinsured
- Varies
- FDA-approved diagnosis
- Must be residing in the US or Puerto Rico
- Patient or doctor's office can call the program to apply. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility.Conditional approval for 90 days.Education and support services are available.This program also provides copay/coinsurance assistance for commercially/privately insured patientsPrescribers can enroll the patient online via the IncyteCARES.com website.
- Pemazyre (pemigatinib) Tablet
More information please phone: 855-452-5234 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Pemazyre (pemigatinib)
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español